Combined Peptide + Stem Cell Therapy in Medellín: The Clinical Sequencing Guide — Pre-Trip Peptide Preconditioning, In-Trip Day-by-Day Choreography, and the 90-Day Post-Stem-Cell Peptide Bridge Protocol That Determines Long-Term Engraftment (2026)

Introduction: The Word "Synergy" Is Doing All the Work in Most Combined-Therapy Articles

Read any article on combined peptide and stem cell therapy and you will see the same sentence in different words: "Peptides and stem cells work synergistically." Followed by a vague paragraph on signaling. Followed by a cost table.

Almost none of those articles answer the questions that actually determine whether your trip works:

• When does each modality get administered, in what order, with what gap between them?
• What happens in the 2 to 4 weeks before you arrive in Medellín?
• What happens in the 90 days after you fly home?
• Why does the clinic doing things in one order get measurably better outcomes than the clinic doing things in another order — using the same molecules?
• What does the day-by-day clinical choreography of a real combined trip actually look like?

That is the gap this guide closes. It is the operational protocol-design article that the combined-therapy cluster is missing.

If you want the foundational comparison — what peptides do, what stem cells do, how they differ at a biological level, which protocols pair, what each costs — read our companion piece: "Peptides vs Stem Cells: Combined Regenerative Therapy at YouMedicine for Americans (2026 Guide)." This article assumes you understand the foundations and goes straight to the sequencing.

It is for U.S. patients evaluating clinics for a combined regenerative trip and for patients already booked who want to know whether the protocol they have been quoted is well-designed or just two infusions on the same day with marketing language wrapped around them.

Why Sequencing Matters: The Four Biological Reasons

The honest reason most combined-therapy articles skip sequencing is that the people writing them do not understand it. Sequencing matters because of four distinct biological mechanisms, each of which has its own clinical timing.

Reason 1: The Recipient Tissue Inflammatory Landscape

Stem cells administered into a tissue that is in active high-grade inflammation behave differently than stem cells administered into a tissue that has been pre-conditioned to a controlled, lower-inflammation state. A tissue with elevated TNF-α, IL-1β, IL-6, and reactive oxygen species is hostile to stem cell viability. The cells that survive long enough to do useful work are dramatically fewer.

This is the biological rationale for the pre-trip peptide preconditioning protocol described later in this guide. Two to four weeks of BPC-157 and TB-500 before stem cell administration shifts the recipient tissue inflammatory landscape into a state that supports stem cell survival and function.

Reason 2: Stem Cell Homing Receptor Expression

Mesenchymal stem cells (MSCs) and adipose-derived stem cells home to injured tissue through specific receptor signaling — most notably the SDF-1/CXCR4 axis. Several therapeutic peptides upregulate the homing signals that recruit administered stem cells to the target tissue rather than allowing them to disperse systemically.

Administering stem cells into a recipient tissue with optimized homing signals dramatically improves the fraction of cells that reach and engraft at the target site versus those that get cleared by the lung first-pass and reticuloendothelial system.

Reason 3: The Paracrine Signaling Amplification Window

The current best understanding of how MSCs work is not that they directly differentiate into replacement tissue (the older simplistic model) — it is that they release a cocktail of paracrine signals (growth factors, cytokines, exosomes) that mobilize and instruct the recipient tissue's own progenitor cells.

This paracrine cascade peaks during a roughly 2 to 8 week window after stem cell administration. Continuing peptide therapy through this window amplifies the recipient tissue's response to the stem cell signaling. Stopping peptide therapy as soon as the patient leaves Medellín shortens the amplification window and underdelivers on the result.

This is the biological rationale for the 90-day post-stem-cell peptide bridge protocol described later in this guide.

Reason 4: Fibroblast and Progenitor Cell Recruitment Timing

The recipient tissue's resident fibroblasts and tissue progenitor cells need to proliferate, migrate, and differentiate to translate stem cell signaling into actual tissue remodeling. GHK-Cu and BPC-157 specifically support this fibroblast and progenitor cascade. Their continued presence during the post-stem-cell remodeling window is what converts cellular signaling into structural change.

The Pre-Trip Peptide Preconditioning Protocol

This is the part of combined therapy that almost nobody outside a small number of serious clinics is doing. Done correctly, it is the difference between a stem cell trip that delivers and a stem cell trip that disappoints.

What Preconditioning Looks Like

Two to four weeks before you arrive in Medellín, you start a peptide preconditioning protocol designed for your specific indication. The exact peptides depend on what you are treating, but the categories are:

• For orthopedic and musculoskeletal indications (joint pain, tendon and ligament injuries, post-surgical recovery, lumbar disc, knee OA, shoulder, Achilles): BPC-157 and TB-500 (thymosin beta-4) are the workhorses. Started 2 to 4 weeks before arrival, they shift the recipient tissue from active inflammation to controlled remodeling state, optimize homing signals, and recruit local progenitor populations into a cycling state primed for the stem cell signaling cascade.
• For systemic anti-aging and longevity protocols: CJC-1295 + Ipamorelin and NAD+ optimization started 2 to 4 weeks before arrival improve the systemic metabolic and growth-factor environment into which the stem cells will be administered.
• For aesthetic and skin indications: GHK-Cu topical preconditioning of the treatment field plus systemic supportive peptides shift the dermal fibroblast population into a primed state.
• For neurological and cognitive indications: Selank, Semax, and Cerebrolysin-class preconditioning (where indicated and supervised) prime the central nervous system environment.

How Preconditioning Is Coordinated With a U.S. Patient

The practical model: your initial Medellín consultation happens 4 to 6 weeks before the trip via video. The Medellín physician designs your protocol, including the preconditioning component. The peptides for the preconditioning phase are either:

• Sourced through a U.S.-licensed compounding pharmacy on a U.S. physician's prescription if you have one
• Or, in the alternative model, delivered to you in advance via the Medellín clinic's compliance pathway

Your clinic walks you through which option applies to your situation. The serious clinics will not just hand you a peptide and say "start whenever" — there is a specific clinical reason for the start date.

What Preconditioning Costs

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

Why Most Clinics Skip Preconditioning

Two reasons. First, it is operationally inconvenient — the clinic has to coordinate with the patient 4 to 6 weeks in advance instead of just running the in-trip protocol. Second, it commits the clinic to a longer relationship with the patient at a price point that is not as easily marketed as the headline trip cost.

The clinics that skip preconditioning are usually the same clinics that skip the post-trip bridge protocol. The result is a stem cell session that produces a measurable but smaller and less durable benefit than the same molecules administered with proper sequencing.

In-Trip Day-by-Day Clinical Choreography

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

The 5-Day Stem Cell Express Protocol — Day-by-Day

Day 1 (Arrival Day): Comprehensive Workup and Baseline. Detailed physical exam, comprehensive blood panel, body composition assessment, indication-specific imaging review (you bring recent MRI/X-ray/ultrasound from home where applicable, or studies are arranged in Medellín), establishment of IV access for the week, and review of your preconditioning compliance. The first IV therapy of the week (typically NAD+ or a metabolic optimization infusion) is administered. No stem cell administration on Day 1. Peptide protocols continue from preconditioning.

Day 2: Pre-Stem-Cell Optimization. The second IV therapy is administered (typically a regenerative-supportive infusion). HBOT (hyperbaric oxygen therapy) session 1 — used to optimize tissue oxygenation and prepare the recipient field. For orthopedic indications, intra-articular or peri-tendinous BPC-157 microinjection may be performed in the target field. For aesthetic indications, microneedling-with-exosomes session 1 with copper peptide post-care. The day's peptide doses continue.

Day 3: Stem Cell Administration Day. This is the central day of the trip. Adipose-derived stem cell collection (mini-liposuction under local anesthesia) and processing. Stem cell microinjection at 100M cells administered to the target tissue or systemic IV depending on indication. Immediate post-injection HBOT session 2 to maximize cellular oxygenation in the early survival window. Peptide doses are timed to support the post-administration cascade — typically a BPC-157 and TB-500 dose 4 to 6 hours post-injection, then continuing on the regular schedule.

Day 4: Post-Stem-Cell Consolidation. HBOT session 3, third IV therapy (typically a recovery and immune-supportive infusion), repeat aesthetic procedure if applicable, exosome microinjection where indicated. Peptide protocol continues. The day is intentionally lower-intensity than Days 2 and 3 to allow consolidation.

Day 5: Final Optimization and Discharge. HBOT session 4, fourth IV therapy, final clinical assessment, written 90-day post-trip peptide bridge protocol issued, continuation supply provided, telemedicine follow-up schedule confirmed. Patient flies home that evening or the following morning.

The total within the 5-day program: 4 IV therapies, 4 HBOT sessions (or up to 6 depending on protocol fit), 1 stem cell microinjection at 100M cells, 1 microneedling-with-exosomes session for aesthetic-included protocols, 1 peri-tendinous or intra-articular peptide microinjection for orthopedic-included protocols, daily systemic peptide protocol throughout, all of it sequenced rather than dumped on the same day.

The point: the total number of treatments delivered (20+) is not what makes the protocol work. The sequencing of those treatments is what makes it work.

The 7- to 10-Day Extended Protocol

For multi-condition patients (covered in detail in our companion guide on multi-condition peptide therapy sequencing), or for patients with more complex indications, the extended protocol runs 7 to 10 days. This adds:

• A second stem cell administration to a different anatomical target (e.g., both knees rather than one, or one shoulder plus one knee)
• Additional HBOT sessions (typically 8 to 10 total over the trip)
• A wider IV therapy menu including PRP processing for additional anatomical targets
• Day-7 or Day-9 booster microinjection of supportive peptides
• More intensive preconditioning and longer post-trip bridge

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

The Post-Stem-Cell 90-Day Peptide Bridge Protocol

This is the second piece of the puzzle that almost nobody writes about, and it is where most patients lose results.

Why 90 Days Is the Critical Window

The paracrine signaling cascade from administered stem cells operates most intensively for about 8 weeks after administration. The recipient tissue's fibroblast and progenitor recruitment, proliferation, and differentiation cycle continues through about week 12. By the 90-day mark, the structural changes the stem cells initiated are either consolidated or lost.

Continuing the right peptides through this 90-day window amplifies the cellular signaling, supports the fibroblast and progenitor response, and converts transient cellular signaling into durable tissue remodeling.

Stopping peptide therapy at the airport — the most common mistake — leaves the stem cell signaling cascade unsupported and underdelivers on the structural endpoint.

What the Bridge Protocol Looks Like

For a typical orthopedic indication, the 90-day post-trip bridge protocol includes:

• Weeks 1 to 4 post-trip: BPC-157 and TB-500 at maintenance doses, daily.
• Weeks 5 to 8 post-trip: BPC-157 continuation, transition TB-500 to lower frequency, addition of CJC-1295 + Ipamorelin for systemic growth-factor support (where indicated for the patient's age and case).
• Weeks 9 to 12 post-trip: BPC-157 weekly maintenance, CJC-1295 + Ipamorelin continuation, condition-specific supportive peptides as warranted.
• Telemedicine check-in at week 4, week 8, and week 12 with the Medellín prescribing physician.
• Lab review at week 6 and week 12: targeted panel for the specific case (hs-CRP, IGF-1 if GH peptides are in the protocol, condition-specific markers).

What Continuation Supply Looks Like

The bridge supply is provided at the end of the in-trip stay in a documented continuation package. The supply path home and the legal nuance is covered in detail in our companion guide on post-trip continuation of care. Briefly: the U.S. legal landscape for peptide continuation supply changed materially after the FDA's 2023 reclassification of bulk peptides under section 503A, and the responsible options today are documented continuation supply with clear personal-use volumes, U.S.-based 503A or 503B compounding pharmacy continuation under U.S. physician supervision, or return-trip cycling.

Cost of the Bridge Phase

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

Condition-Specific Sequencing for the Four Most Common Orthopedic Indications

Generic combined-therapy protocols underdeliver. Here are the actual condition-specific sequencing approaches for the four most common orthopedic indications at YouMedicine.

Partial Rotator Cuff Tear (Supraspinatus Most Commonly)

• Preconditioning (4 weeks): BPC-157 systemic plus TB-500 systemic. Avoid corticosteroid injections during this window.
• In-trip: Day 2 peri-tendinous BPC-157 microinjection at the supraspinatus footprint, Day 3 ultrasound-guided stem cell microinjection at the partial-thickness defect, Day 4 PRP supplementation if indicated, all under HBOT and IV support.
• Bridge (90 days): BPC-157 daily continuation, TB-500 weekly, structured physical therapy graded to the healing timeline. Repeat ultrasound at week 12 to assess response.

Bone-on-Bone Knee Osteoarthritis (Grade III–IV Kellgren-Lawrence)

• Preconditioning (4 weeks): BPC-157 systemic, NAD+ optimization, weight management protocol where applicable. Avoid intra-articular corticosteroid for at least 8 weeks before stem cell administration (corticosteroid suppresses the recipient signaling environment).
• In-trip: Day 3 ultrasound-guided intra-articular stem cell microinjection, Day 4 PRP supplementation if indicated, HBOT throughout. For bilateral cases, the extended 7-day protocol with second-knee administration on Day 5.
• Bridge (90 days): BPC-157 continuation, structured low-impact rehab progression, second intra-articular booster microinjection at week 8 to 12 where indicated.
• Honest expectation framing: Grade IV bone-on-bone OA does not become Grade I OA. A meaningful subset of patients delays or avoids arthroplasty by 1 to 5 years; another subset improves function and pain meaningfully without changing the radiographic grade; another subset proceeds to arthroplasty on a timeline they would have proceeded anyway. The protocol is honest about which subset you are likely to be in based on your imaging, age, and baseline function.

Lumbar Disc Degeneration (Symptomatic Degenerative Disc Disease)

• Preconditioning (4 weeks): BPC-157 systemic, structured spine-stabilization rehab progression, ergonomic and lifestyle factor modification.
• In-trip: Day 3 fluoroscopy-guided intradiscal stem cell microinjection at the symptomatic level, Day 4 epidural or peri-radicular supportive injection where indicated.
• Bridge (90 days): BPC-157 continuation, ongoing spine-stabilization rehab, MRI re-assessment at month 6 to 12.
• Selection matters: not every degenerative disc is a candidate. Pre-trip MRI review is part of the workup.

Achilles Tendinopathy (Mid-Substance, Insertional, or Post-Partial-Tear Recovery)

• Preconditioning (4 weeks): BPC-157 systemic plus TB-500 systemic, eccentric loading rehab program initiation, footwear and activity modification.
• In-trip: Day 2 peri-tendinous BPC-157 microinjection, Day 3 ultrasound-guided stem cell microinjection at the affected tendon segment, Day 4 PRP supplementation if indicated.
• Bridge (90 days): BPC-157 daily, TB-500 weekly, structured eccentric and progressive loading rehab, return-to-sport progression mapped to tissue healing timeline.

Timing Pitfalls That Cause Combinations to Underperform

In our experience auditing protocols other patients have been through elsewhere, here are the specific timing errors that explain underperformance:

• Stem cells administered on Day 1 of the trip, before the recipient tissue has been preconditioned. The cells encounter a high-inflammation, low-homing-signal environment.
• No peptide preconditioning at all — patient flies down, gets the stem cell injection, flies home. Predictable, modest result.
• Peptides and stem cells administered as a single combined infusion with no thought to sequencing. The combined infusion is operationally convenient but biologically non-optimal.
• Patient stops peptides at the airport. Loss of 60 to 75 percent of the achievable engraftment window.
• High-dose NSAIDs taken throughout the protocol window for "pain management." NSAIDs blunt the controlled inflammation that the protocol depends on.
• Systemic corticosteroid injection within the 8 weeks before stem cell administration or during the 12 weeks after. Corticosteroids suppress the cellular signaling cascade.
• Patient adds an immunosuppressant or biologic (for an unrelated condition) during the 90-day window without coordination with the prescribing physician. The immune signaling the protocol relies on is altered.
• Aggressive return to high-load activity in the first 4 to 6 weeks post-stem-cell administration before the cellular and tissue remodeling has consolidated. Common in athletes — the tissue is biologically not ready.

Three Medications and Supplements You Must NOT Take During the Protocol Window

This is non-negotiable. Discuss with your prescribing physician any current use of:

• High-dose NSAIDs (ibuprofen, naproxen, diclofenac, celecoxib) at sustained therapeutic doses. Occasional acetaminophen for incidental pain is fine. Sustained NSAIDs blunt the protocol.
• Systemic corticosteroids (prednisone, methylprednisolone) and corticosteroid injections within the 8 weeks before through 12 weeks after stem cell administration. If you take corticosteroids for a chronic condition (autoimmune disease, severe asthma, etc.), this is a screening conversation that must happen before you book the trip.
• Immunosuppressants and biologics (TNF inhibitors, IL-17 inhibitors, JAK inhibitors, methotrexate, cyclosporine, etc.) that materially alter immune signaling. Coordination with your treating specialist is required. In some cases, combined regenerative therapy is contraindicated; in others, it can proceed with timing modification.

This is one of the most common screening issues that surfaces during the YouMedicine pre-trip workup and one of the most common reasons patients are asked to delay or modify the trip.

Red Flags That Signal a Clinic Does Not Understand Sequencing

• Quotes you a stem cell trip with no preconditioning phase and no post-trip peptide bridge.
• Schedules stem cell administration on Day 1 of arrival.
• Mixes peptides and stem cells into a single infusion bag.
• Cannot explain the biological rationale for the order in which they sequence the protocol.
• Recommends NSAIDs for post-procedure pain management in the first 6 weeks post-stem-cell.
• Will administer stem cells without a 4-week corticosteroid washout (where applicable to your medication history).
• Markets "stem cells plus peptides" as a category but uses the same fixed schedule for every patient regardless of indication.
• Does not screen for immunosuppressant or biologic use.
• Does not discuss the 90-day post-trip window.
• Does not provide a written sequencing protocol.

Who Is and Is NOT a Candidate for Combined Therapy

Good candidates

• Orthopedic indications with imaging-confirmed pathology amenable to regenerative protocol (partial tendon and ligament tears, mild-to-moderate joint degeneration, certain disc pathology, post-injury and post-surgical recovery cases).
• Anti-aging and longevity indications in patients without active malignancy or major contraindication.
• Aesthetic indications including skin remodeling, scar revision, hair restoration as part of a multi-modality protocol.
• Patients willing and able to comply with the preconditioning phase, in-trip schedule, and 90-day post-trip bridge.

Not candidates

• Active malignancy or recent malignancy (typically within 5 years; case-by-case).
• Active untreated infection.
• Pregnancy and breastfeeding.
• Severe organ dysfunction precluding the procedure.
• Patients on active immunosuppressant or biologic therapy that cannot safely be paused or coordinated.
• Patients with end-stage radiographic disease where structural change exceeds what regenerative protocol can address (e.g., true bone-on-bone end-stage Grade IV OA where arthroplasty is the appropriate intervention).
• Patients seeking guarantees that defy the biology.
• Patients unwilling to commit to the preconditioning and bridge phases.

Frequently Asked Questions

1. Do I really need to do peptide preconditioning, or can I just show up and do the stem cells?

You can show up and do the stem cells. You will get a more modest, less durable result than you would with preconditioning. Whether the difference is worth the additional cost and effort of a preconditioning phase is a case-by-case discussion based on your indication and your goals.

2. How long before the trip do I start preconditioning?

Typically 2 to 4 weeks. Specific to your case.

3. Can I do the preconditioning with peptides I already have from a U.S. compounding pharmacy?

Yes, if the molecule, dose, and source can be verified. Coordinate with your Medellín prescribing physician in your initial telemedicine consultation.

4. What if I have to take an NSAID for an unrelated condition during the protocol window?

Discuss with your prescribing physician. There are usually alternative pain-management strategies that do not blunt the protocol.

5. Is a single-day combined infusion the same as a properly sequenced protocol?

No. The biology is different. A single-day combined infusion is operationally convenient and easier to bill but underdelivers on the structural endpoint compared to a properly sequenced protocol.

6. How long does a properly sequenced combined protocol benefit last?

For orthopedic indications with appropriate selection, the structural and functional improvements typically persist 1 to 5 years, with periodic booster microinjections extending the timeline. For systemic anti-aging indications, the protocol benefits sustain as long as the supportive lifestyle and continuation of supportive peptide therapy are maintained.

7. Can I do a combined protocol if I am on TRT (testosterone replacement)?

Yes, in most cases. TRT is generally compatible with the protocol. Your prescribing physician will coordinate.

8. Can I do a combined protocol if I am on a GLP-1 (semaglutide, tirzepatide)?

Yes. GLP-1 therapy is generally compatible. Coordination with your prescribing physician for any dose modification during the trip.

9. What if I have already had stem cell therapy elsewhere and want to do a "booster" protocol at YouMedicine?

Possible. Pre-trip workup includes review of prior protocol, what was administered, when, and what the response was. Bridge protocol is designed to extend or rescue the prior result.

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

No. It is well-designed for the typical regenerative trip — single primary indication with systemic anti-aging support, patient with reasonable health status, willing to commit to the integrated 16-week arc. For multi-condition or more complex cases, the extended 7- to 10-day protocol is more appropriate. Your initial consultation determines the fit.

Cross-Linked Companion Guides

• Peptides vs Stem Cells: Combined Regenerative Therapy at YouMedicine for Americans (2026 Guide) — the foundational comparison.
• Knee Pain AND Gut Issues AND Back Pain: Multi-Condition Peptide Therapy Sequencing (2026) — for polysymptomatic patients.
• After Your Medellín Peptide Trip: Post-Trip Continuation-of-Care Guide (2026) — the supply-path and cross-border compounding detail for the bridge phase.
• Verifying Your Medellín Peptide Clinic on Day 1 (2026) — credential, sourcing, and adverse event verification.
• Peptide Therapy True Total Cost (Medellín, 2026) — transparent cost framework including preconditioning, in-trip, and bridge phases.
• GHK-Cu as a Post-Procedure Recovery Accelerator in Medellín (2026) — for patients including aesthetic procedures in the protocol.

Who This Article Is NOT For

• Patients seeking a single-day combined infusion on Day 1 of arrival with no preconditioning and no bridge protocol. The biology does not support that as a protocol design.
• Patients seeking guarantees that bone-on-bone end-stage osteoarthritis becomes Grade I OA from a stem cell injection. The biology does not deliver that.
• Patients on active corticosteroid therapy or immunosuppressants who cannot coordinate timing with their treating specialist.
• Patients with active malignancy or recent malignancy outside case-by-case clearance.
• Patients seeking a 5-day vacation rather than a structured 16-week clinical protocol with the trip as the central component.

The Bottom Line

The phrase "peptides and stem cells work synergistically" is true at a hand-wave level. It also explains nothing useful about how to design a protocol that actually delivers.

The combined regenerative protocol that delivers durable structural and functional improvement is sequenced across three phases:

• Pre-trip preconditioning (2 to 4 weeks) to shift the recipient tissue inflammatory landscape and optimize stem cell homing signals.
• In-trip clinical choreography (5 to 10 days) with stem cell administration timed to the optimized recipient field, supported by HBOT, IV therapy, peri-tendinous or intra-articular peptide microinjection, and aesthetic procedures where indicated.
• Post-trip 90-day peptide bridge protocol to amplify the paracrine signaling cascade and consolidate cellular signaling into structural remodeling.

The clinics that understand the sequencing get measurably better outcomes than the clinics running parallel infusions on the same day. The molecules are the same. The protocol design is what differs.

If you are evaluating clinics for a combined regenerative trip and the protocol you have been quoted does not include a preconditioning phase and a post-trip bridge protocol, ask why. If the answer is unclear or evasive, that is informative.

Schedule a Consultation

YouMedicine in El Poblado, Medellín designs combined peptide and stem cell protocols as integrated 16-week clinical arcs — with the in-trip 5- to 10-day intensive as the central component, but with the preconditioning and post-trip bridge phases that turn the trip into a durable result.

• Email: wellness@youmedicine.co
• WhatsApp: +57 324 576 1913
• Location: El Poblado, Medellín, Colombia

In your first message, share:

• Your primary indication or indications (orthopedic site, longevity goals, aesthetic goals, etc.)
• Recent imaging where applicable (MRI, X-ray, ultrasound) — we can review before the consultation
• Your medical history and current medications, including NSAIDs, corticosteroids, immunosuppressants, biologics, TRT, GLP-1, and any other relevant therapy
• Whether you have had prior stem cell therapy or PRP elsewhere
• Your timeline preference for travel

Every plan is personalized. Message us on WhatsApp and we'll send your quote after reviewing your case.

We will design the integrated 16-week protocol — preconditioning, in-trip, and bridge — and walk you through the sequencing rationale for your specific case before you book.

YouMedicine — El Poblado, Medellín. Wellness starts with YOU.